Target intelligence / Profile preview

Large tumor suppressor kinase 1 (LATS1)

Target
LATS1
Molecular classification
Enzyme, Serine/threonine kinase, AGC kinase family, Tumor suppressor, Negative regulator in the Hippo pathway
01

Overview

Large tumor suppressor kinase 1 (LATS1) is a serine/threonine kinase and core component of the Hippo signaling pathway, critical for regulating cell proliferation, apoptosis, and organ size. LATS1 phosphorylates and inactivates YAP and TAZ, preventing their nuclear localization and transcriptional activation of proliferative genes. Mutations or loss of LATS1 function are associated with increased susceptibility to various cancers due to loss of cell cycle regulation and failure of apoptosis, supported by mouse knockout studies that show increased tumorigenesis. LATS1 also interacts with cytoskeletal proteins, directly binds and inhibits actin polymerization, and localizes to structures such as centrosomes and mitotic apparatus. As a negative regulator of cell migration, LATS1's suppression of metastasis further cements its tumor suppressor role[1][2][3][4][5].

Other names
Large tumor suppressor protein 1LATS1Warts homolog (WARTS)LATShLATS1
02

Mechanism of action

Inhibitors or activators would modulate phosphorylation of YAP/TAZ and thus impact cell proliferation and apoptosis[5]

03

Biological functions

Tumor suppressionCell cycle regulationApoptosisMaintenance of ploidyRegulation of cell proliferationInhibition of cell migrationRegulation of actin polymerizationRegulation of cytokinesis
04

Disease associations

CancerOrganomegaly via Hippo pathway dysregulation
05

Safety considerations

Potential risk of tumor development or loss of normal organ size/homeostasis if activity is disruptedNo current data on approved drug-related safety issues
06

Interacting drugs

None explicitly listed in current references; no approved direct LATS1-targeting drugs as of cutoff
07

Biomarkers

LATS1 protein/mRNA levels (used as a biomarker in some cancer studies)

Beyond the preview

Go deeper on Large tumor suppressor kinase 1 (LATS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Large tumor suppressor kinase 1 (LATS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call